Kowa Research Institute, Inc. is responsible for the clinical development of Kowa Company’s new drugs in the United States. The company is a division of Kowa Co., Ltd. headquartered in Nagoya, Japan. Kowa Research Institute was established in 1997 in California, began operations in the RTP area of North Carolina in 2003, and expanded to Boston, Massachusetts in 2018 with the establishment of Kowa Pharma Development Co.